476 related articles for article (PubMed ID: 15647840)
61. Osteoblasts-derived BMP-2 enhances the motility of prostate cancer cells via activation of integrins.
Lai TH; Fong YC; Fu WM; Yang RS; Tang CH
Prostate; 2008 Sep; 68(12):1341-53. PubMed ID: 18512729
[TBL] [Abstract][Full Text] [Related]
62. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.
Recchia AG; Musti AM; Lanzino M; Panno ML; Turano E; Zumpano R; Belfiore A; Andò S; Maggiolini M
Int J Biochem Cell Biol; 2009 Mar; 41(3):603-14. PubMed ID: 18692155
[TBL] [Abstract][Full Text] [Related]
63. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.
Zhou J; Ma J; Zhang BC; Li XL; Shen SR; Zhu SG; Xiong W; Liu HY; Huang H; Zhou M; Li GY
J Cell Physiol; 2004 Jul; 200(1):89-98. PubMed ID: 15137061
[TBL] [Abstract][Full Text] [Related]
64. Cytotoxicity of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone in androgen-dependent and -independent prostate cancer cell lines.
Copeland RL; Das JR; Bakare O; Enwerem NM; Berhe S; Hillaire K; White D; Beyene D; Kassim OO; Kanaan YM
Anticancer Res; 2007; 27(3B):1537-46. PubMed ID: 17595773
[TBL] [Abstract][Full Text] [Related]
65. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.
Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi DF; Asara G; Casabona D; Frau M; Seddaiu MA; Feo F
Hepatology; 2002 Jun; 35(6):1341-50. PubMed ID: 12029619
[TBL] [Abstract][Full Text] [Related]
66. Ebp1, an ErbB-3 binding protein, interacts with Rb and affects Rb transcriptional regulation.
Xia X; Cheng A; Lessor T; Zhang Y; Hamburger AW
J Cell Physiol; 2001 May; 187(2):209-17. PubMed ID: 11268000
[TBL] [Abstract][Full Text] [Related]
67. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells.
Sugama R; Koike T; Imai Y; Nomura-Furuwatari C; Takaoka K
Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197
[TBL] [Abstract][Full Text] [Related]
68. E2F1 and p53 are dispensable, whereas p21(Waf1/Cip1) cooperates with Rb to restrict endoreduplication and apoptosis during skeletal myogenesis.
Jiang Z; Liang P; Leng R; Guo Z; Liu Y; Liu X; Bubnic S; Keating A; Murray D; Goss P; Zacksenhaus E
Dev Biol; 2000 Nov; 227(1):8-41. PubMed ID: 11076674
[TBL] [Abstract][Full Text] [Related]
69. Up-regulation of p21(WAF1/CIP1) levels leads to growth suppression of prostate cancer cell lines.
Sugibayashi R; Kiguchi Y; Shimizu T; Suzuki T; Hamada H; Takeda K
Anticancer Res; 2002; 22(2A):713-9. PubMed ID: 12014641
[TBL] [Abstract][Full Text] [Related]
70. CD30-mediated cell cycle arrest associated with induced expression of p21(CIP1/WAF1) in the anaplastic large cell lymphoma cell line Karpas 299.
Hübinger G; Müller E; Scheffrahn I; Schneider C; Hildt E; Singer BB; Sigg I; Graf J; Bergmann L
Oncogene; 2001 Feb; 20(5):590-8. PubMed ID: 11313991
[TBL] [Abstract][Full Text] [Related]
71. Identification and characterization of PLZF as a prostatic androgen-responsive gene.
Jiang F; Wang Z
Prostate; 2004 Jun; 59(4):426-35. PubMed ID: 15065091
[TBL] [Abstract][Full Text] [Related]
72. Differential regulation of Rb family proteins and prohibitin during camptothecin-induced apoptosis.
Fusaro G; Wang S; Chellappan S
Oncogene; 2002 Jul; 21(29):4539-48. PubMed ID: 12085232
[TBL] [Abstract][Full Text] [Related]
73. The E2F1-3 transcription factors are essential for cellular proliferation.
Wu L; Timmers C; Maiti B; Saavedra HI; Sang L; Chong GT; Nuckolls F; Giangrande P; Wright FA; Field SJ; Greenberg ME; Orkin S; Nevins JR; Robinson ML; Leone G
Nature; 2001 Nov; 414(6862):457-62. PubMed ID: 11719808
[TBL] [Abstract][Full Text] [Related]
74. P130 and its truncated form mediate p53-induced cell cycle arrest in Rb(-/-) Saos2 cells.
Gao CF; Ren S; Wang J; Zhang SL; Jin F; Nakajima T; Ikeda M; Tsuchida N
Oncogene; 2002 Oct; 21(49):7569-79. PubMed ID: 12386819
[TBL] [Abstract][Full Text] [Related]
75. Bone morphogenetic protein-2 enhances osterix gene expression in chondrocytes.
Yagi K; Tsuji K; Nifuji A; Shinomiya K; Nakashima K; DeCrombrugghe B; Noda M
J Cell Biochem; 2003 Apr; 88(6):1077-83. PubMed ID: 12647290
[TBL] [Abstract][Full Text] [Related]
76. Increased expression of bone morphogenetic protein-7 in bone metastatic prostate cancer.
Masuda H; Fukabori Y; Nakano K; Takezawa Y; CSuzuki T; Yamanaka H
Prostate; 2003 Mar; 54(4):268-74. PubMed ID: 12539225
[TBL] [Abstract][Full Text] [Related]
77. Alterations of cell cycle regulators affecting the RB pathway in nonfamilial retinoblastoma.
Orjuela M; Orlow I; Dudas M; Ponce-Castañeda MV; Ridaura C; Leal C; Salazar A; Abramson D; Gerald W; Cordon-Cardo C
Hum Pathol; 2001 May; 32(5):537-44. PubMed ID: 11381373
[TBL] [Abstract][Full Text] [Related]
78. Retinoic acid- and bone morphogenetic protein 4-induced apoptosis in P19 embryonal carcinoma cells requires p27.
Glozak MA; Rogers MB
Exp Cell Res; 2001 Aug; 268(2):128-38. PubMed ID: 11478839
[TBL] [Abstract][Full Text] [Related]
79. RhoE inhibits cell cycle progression and Ras-induced transformation.
Villalonga P; Guasch RM; Riento K; Ridley AJ
Mol Cell Biol; 2004 Sep; 24(18):7829-40. PubMed ID: 15340047
[TBL] [Abstract][Full Text] [Related]
80. Role of RUNX3 in bone morphogenetic protein signaling in colorectal cancer.
Lee CW; Ito K; Ito Y
Cancer Res; 2010 May; 70(10):4243-52. PubMed ID: 20442291
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]